A review of endophilin proteins in cancer and other diseases
Original title: Endophilin Proteins in Membrane Dynamics, Neurodegeneration, Cancer, and Cardiovascular Disease.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of where the science stands, not a new result or a treatment.
The short version
This is a look back at lab research on a group of proteins that may help cancer grow or spread.
What was studied. Scientists reviewed what is already known about a family of proteins called endophilins. The human family has five main members, each made by its own gene.
What they found. These proteins help shape the outer wall of cells and move things in and out. One member, endophilin A1, can help hold tumors back, and its gene is often lost or turned down in some cancers. Another member, endophilin A2, helps cancer spread. In glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary, a small piece of genetic material called miR-330 acts on the endophilin A1 gene.
What this means, and what it doesn't
What it could mean: Nothing about care today changes because of this. It gives researchers ideas about how some brain tumors may grow, and where to look next.
What it doesn't mean: This is not a new treatment. It is a review of lab science, not a test in people. No drug was tried here, and no one was helped or harmed. It is not a cure and it is not a promise of one. Anything useful from this work would take many years and many more studies.
Source: PubMed, August 18, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.